Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Wet Age-related Macular Degeneration”

353 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 353 results

Testing effectiveness (Phase 2)Ended earlyNCT00414206
What this trial is testing

Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
CoMentis 343
Large-scale testing (Phase 3)UnknownNCT04572698
What this trial is testing

Compare LY09004 and Eylea in the Treatment of Wet Age-related Macular Degeneration（wAMD）

Who this might be right for
Age Related Macular Degeneration
Luye Pharma Group Ltd. 416
Early research (Phase 1)UnknownNCT04468997
What this trial is testing

The Study of Drug 601 in Patients With Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 67
Testing effectiveness (Phase 2)Ended earlyNCT02387957
What this trial is testing

A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)

Who this might be right for
Age-Related Macular Degeneration
Ophthotech Corporation 63
Large-scale testing (Phase 3)UnknownNCT04667039
What this trial is testing

Efficacy, Safety, pharmacokinetiсs, Immunogenicity of GNR-067 and Lucentis®

Who this might be right for
Age Related Macular Degeneration (ARMD)
AO GENERIUM 408
Not applicableStudy completedNCT01318941
What this trial is testing

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Who this might be right for
Wet Age Related Macular Degeneration, Diabetic Macular Edema, Retinal Vein OcclusionWet Age Related Macular DegenerationDiabetic Macular Edema+1 more
Novartis Pharmaceuticals 30,490
Not applicableStudy completedNCT01899963
What this trial is testing

Time to Treatment Utilizing a Tele-Retinal Referral System for wAMD and DME: A Pilot Study

Who this might be right for
Wet Age Related Macular DegenerationDiabetic Macular Edema
McMaster University 83
Post-approval studies (Phase 4)Study completedNCT01896284
What this trial is testing

Study to Evaluate Efficacy of Aflibercept in Neovascular Age-related Macular Degeneration Patients Non Responders to Anti-Vascular Endothelial Growth Factor

Who this might be right for
Wet Macular Degeneration
Barcelona Macula Foundation 46
Large-scale testing (Phase 3)Study completedNCT05345236
What this trial is testing

Compare QL1207 to Eylea® in Subjects With Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Qilu Pharmaceutical Co., Ltd. 366
Not applicableStudy completedNCT02287298
What this trial is testing

Triple Combination Therapy of Choroidal Neovascularization in AMD, a Cost Effect and Efficient Therapeutic Treatment

Who this might be right for
Exudative Macular Degeneration
The Retina Center of St. Louis County, PC 400
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06839339
What this trial is testing

Efficacy and Safety of AL-001 Ophthalmic Injection in Subjects with WAMD

Who this might be right for
Wet Age-related Macular Degeneration (wAMD)
Beijing Anlong Biopharmaceutical Co., Ltd. 40
Not applicableUnknownNCT01310686
What this trial is testing

Genetics Study of Wet Age-Related Macular Degeneration (AMD) Non-Responders to Vascular Endothelial Growth Factor (VEGF) Therapy

Who this might be right for
Wet AMD
West Coast Retina Medical Group, Inc. 40
Not applicableLooking for participantsNCT07255859
What this trial is testing

CRYSTALSIGHT Cohort 2.0

Who this might be right for
Maculopathy
Tan Tock Seng Hospital 60
Testing effectiveness (Phase 2)Study completedNCT04200248
What this trial is testing

A Phase II Study of RBM-007 Alone and RBM-007 With Eylea® in Subjects With Wet Age-related Macular Degeneration

Who this might be right for
Exudative Age-related Macular Degeneration
Ribomic USA Inc 94
Large-scale testing (Phase 3)Study completedNCT04516278
What this trial is testing

A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders

Who this might be right for
Age-related Macular DegenerationNeovascular Age-related Macular DegenerationWet Macular Degeneration+2 more
Outlook Therapeutics, Inc. 195
Testing effectiveness (Phase 2)Study completedNCT02121353
What this trial is testing

Safety Study of PF582 Versus Lucentis in Patients With Age Related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration (AMD)
Pfenex, Inc 25
Not applicableStudy completedNCT02218177
What this trial is testing

Intraocular Cytokines in Non-responders to Ranibizumab Treatment for Neovascular AMD

Who this might be right for
Age Related Macular Degeneration
University Health Network, Toronto 30
Testing effectiveness (Phase 2)Study completedNCT03725501
What this trial is testing

Evaluation of the Safety and Efficacy of ALS-L1023 Administered in Combination With Ranibizumab in Patients With Wet-AMD

Who this might be right for
Age-Related Macular Degeneration
AngioLab, Inc. 126
Testing effectiveness (Phase 2)Active Not RecruitingNCT06704009
What this trial is testing

NT-101 Topical Ophthalmic Solution in Patients With Wet AMD

Who this might be right for
Wet Age Related Macular DegenerationWet AMD
NexThera Co., Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT03861234
What this trial is testing

Test Different Doses of BI 836880 in Patients With an Eye Disease Called Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Macular Degeneration
Boehringer Ingelheim 43
Load More Results